ClinVar Miner

Submissions for variant NM_001035.3(RYR2):c.5524A>T (p.Ile1842Phe)

dbSNP: rs1553522483
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000617527 SCV000734890 uncertain significance Cardiovascular phenotype 2016-06-21 criteria provided, single submitter clinical testing The p.I1842F variant (also known as c.5524A>T), located in coding exon 37 of the RYR2 gene, results from an A to T substitution at nucleotide position 5524. The isoleucine at codon 1842 is replaced by phenylalanine, an amino acid with highly similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), Exome Aggregation Consortium (ExAC), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6175 samples (12350 alleles) with coverage at this position. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.